TapewireFind a company

person · Reporting owner

COSTLEY GARY E

Disclosed activity across 2 companies

Tapewire entity
147350
SEC CIK
0001202277

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Prestige Consumer Healthcare Inc.PBH · Entity 4350DirectorAugust 04, 2020August 06, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Prestige Consumer Healthcare Inc.

Report date August 04, 2020 · Filed August 06, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivativeDirect50,200 Reported balance After 2020-08-04 transaction · row 1
1 source row

Row 1 · 2020-08-04 · Grant · Acquired 3,732 · Balance 50,200

F1: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

TIFFANY & CO

Report date May 24, 2018 · Filed June 04, 2018

Section 16 reporting ended · disclosed 2018-06-04. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock $.01 ParSEC Table I · non-derivativeDirect10,962 Reported balance Holding disclosure · report date 2018-05-24 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 10,962

F1: 9,029 shares in the total are vested restricted stock units. The reporting person has elected to defer the maturity date of the vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceased to be a director.

Filing footnotes · ownership attribution and instrument terms

F1: 9,029 shares in the total are vested restricted stock units. The reporting person has elected to defer the maturity date of the vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceased to be a director.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2020 Filed Aug 6, 2020 21:24 UTC Prestige Consumer Healthcare Inc. PBH · Entity 4350 GrantCommon Stock, par value $0.01 per share 3,732 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-091551 · tm2023357d7_4.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,200

F1 · shares: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control.

Read SEC document
July 30, 2019 Filed Aug 1, 2019 20:24 UTC Prestige Consumer Healthcare Inc. PBH · Entity 4350 GrantCommon Stock, par value $0.01 per share 4,183 $0.00 $0.00
Disclosure

SEC source: 0001144204-19-037209 · tv526531_4.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,468

F1 · shares: The Reporting Person received 4,183 restricted stock units (equal to $145,000 divided by the closing stock price of $34.67 on July 30, 2019) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control.

Read SEC document
July 31, 2018 Filed Aug 1, 2018 20:01 UTC Prestige Consumer Healthcare Inc. PBH · Entity 4350 GrantCommon Stock, par value $0.01 per share 3,779 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-041351 · tv499904_4.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,285

F1 · shares: The Reporting Person received 3,779 restricted stock units (equal to $135,000 divided by the closing stock price of $35.73 on July 31, 2018) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability.

Read SEC document
February 05, 2018 Filed Feb 5, 2018 21:04 UTC Prestige Consumer Healthcare Inc. PBH · Entity 4350 PurchaseCommon Stock, par value $0.01 per share 7,500 $35.47 $266,025.00
Disclosure

SEC source: 0001144204-18-005698 · tv484888_form4.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,506

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 2,878 $0.00 Strike: $61.12 $0.00
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 7

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock $.01 Par · 2,878 shares

Expires 2022-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Granted Pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16(b)-3, on May 17, 2012. The option vested in full on the grant date.

F8 · balance_after: Total grant 2,878 shares. 0 shares previously exercised.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 2,477 $0.00 Strike: $70.28 $0.00
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 6

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock $.01 Par · 2,477 shares

Expires 2021-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3, on May 19, 2011. The option vested in full on the grant date.

F6 · balance_after: Total grant 2,477 shares. 0 shares previously exercised.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 3,860 $0.00 Strike: $42.37 $0.00
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 5

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock $.01 Par · 3,860 shares

Expires 2020-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3, on May 20, 2010. The option vested in full on the first business day following the grant date.

F4 · balance_after: Total grant 3,860 shares. 0 shares previously exercised.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 SaleCommon Stock $.01 Par 9,215 $109.33 $1,007,480.56
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 4

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,962

F2 · price: The price in Column 4 is a weighted average price. The price actually received ranged from $109.3301 to $109.3400 per share. The reporting person's broker has provided to the issuer and the issuer will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionCommon Stock $.01 Par 2,878 $61.12 $175,903.36
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 3

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionCommon Stock $.01 Par 2,477 $70.28 $174,083.56
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 2

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability.

Read SEC document
January 24, 2018 Filed Jan 25, 2018 17:17 UTC TIFFANY & CO TIF · Entity 143953 Exercise / conversionCommon Stock $.01 Par 3,860 $42.37 $163,548.20
Disclosure

SEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:25 UTC TIFFANY & CO TIF · Entity 143953 GrantDividend Equivalent Units · Derivative 5 $0.00 $0.00
Disclosure

SEC source: 0000098246-18-000049 · wf-form4_151579950498829.xml · derivative · entry 2

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18

Underlying: Common Stock $.01 Par · 5 shares

Expires not disclosed

F2 · security: Registrant's transfer agent maintains a direct stock purchase program for Registrant's stockholders with a dividend reinvestment feature. Accordingly, pursuant to Rule 16a-11, dividend equivalent units will no longer be reported on a Form 4 at the time of accrual.

F3 · derivative.exercise_price: Represents dividend equivalent units accrued on January 10, 2018 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis.

F4 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

F4 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

Read SEC document
October 10, 2017 Filed Oct 13, 2017 16:36 UTC TIFFANY & CO TIF · Entity 143953 GrantDividend Equivalent Units · Derivative 6 $0.00 $0.00
Disclosure

SEC source: 0000098246-17-000271 · wf-form4_150792698008556.xml · derivative · entry 2

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12

Underlying: Common Stock $.01 Par · 6 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents dividend equivalent units accrued on October 10, 2017 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

F3 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

Read SEC document
August 01, 2017 Filed Aug 3, 2017 19:30 UTC Prestige Consumer Healthcare Inc. PBH · Entity 4350 GrantCommon Stock, par value $0.01 per share 2,564 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-040281 · v472274_4.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,006

F1 · shares: The Reporting Person received 2,564 restricted stock units (equal to $135,000 divided by the closing stock price of $52.64 on August 1, 2017) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability.

Read SEC document
July 10, 2017 Filed Jul 12, 2017 17:19 UTC TIFFANY & CO TIF · Entity 143953 GrantDividend Equivalent Units · Derivative 6 $0.00 $0.00
Disclosure

SEC source: 0000098246-17-000187 · wf-form4_149989435111228.xml · derivative · entry 2

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6

Underlying: Common Stock · 6 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents dividend equivalent units accrued on July 10, 2017 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

F3 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

Read SEC document
May 25, 2017 Filed May 30, 2017 18:21 UTC TIFFANY & CO TIF · Entity 143953 GrantNon-Qualified Stock Option (Right to Buy) · Derivative 5,450 $0.00 Strike: $85.82 $0.00
Disclosure

SEC source: 0000098246-17-000141 · wf-form4_149618289039690.xml · derivative · entry 2

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,450

Underlying: Common Stock $.01 Par · 5,450 shares

Expires 2027-05-25

F4 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The option is exercisable on the first business day following the grant date.

Read SEC document
May 25, 2017 Filed May 30, 2017 18:21 UTC TIFFANY & CO TIF · Entity 143953 GrantCommon Stock $.01 Par 933 $0.00 $0.00
Disclosure

SEC source: 0000098246-17-000141 · wf-form4_149618289039690.xml · nonDerivative · entry 1

COSTLEY GARY E · CIK 0001202277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,962

F1 · shares: Includes 933 unvested restricted stock units, which will vest in accordance with their terms on the earlier of the one-year anniversary of the grant date, or the termination of the reporting person's service as a director due to death or disability.

F2 · price: Given for no consideration.

F3 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. The reporting person has elected to defer the maturity date of the 9,029 vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.